Departments of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Department of Biochemistry, Hanoi Medical University, Hanoi, Vietnam.
Sci Rep. 2018 Dec 14;8(1):17860. doi: 10.1038/s41598-018-36215-4.
Cytoglobin (CYGB), discovered in hepatic stellate cells (HSCs), is known to possess a radical scavenger function, but its pathophysiological roles remain unclear. Here, for the first time, we generated a new transgenic (TG) mouse line in which both Cygb and mCherry reporter gene expression were under the control of the native Cygb gene promoter. We demonstrated that the expression of Cygb-mCherry was related to endogenous Cygb in adult tissues by tracing mCherry fluorescence together with DNA, mRNA, and protein analyses. Administration of a single dose (50 mg/kg) of thioacetamide (TAA) in Cygb-TG mice resulted in lower levels of alanine transaminase and oxidative stress than those in WT mice. After 10 weeks of TAA administration, Cygb-TG livers exhibited reduced neutrophil accumulation, cytokine expression and fibrosis but high levels of quiescent HSCs. Primary HSCs isolated from Cygb-TG mice (HSC) exhibited significantly decreased mRNA levels of α-smooth muscle actin (αSMA), collagen 1α1, and transforming growth factor β-3 after 4 days in culture relative to WT cells. HSCs were resistant to HO-induced αSMA expression. Thus, cell-specific overexpression of Cygb attenuates HSC activation and protects mice against TAA-induced liver fibrosis presumably by maintaining HSC quiescence. Cygb is a potential new target for antifibrotic approaches.
细胞球蛋白(CYGB)最初在肝星状细胞(HSCs)中被发现,具有清除自由基的功能,但它的病理生理作用仍不清楚。在这里,我们首次生成了一个新的转基因(TG)小鼠品系,其中 Cygb 和 mCherry 报告基因的表达均受内源性 Cygb 基因启动子的控制。我们通过追踪 mCherry 荧光与 DNA、mRNA 和蛋白质分析,证明了 Cygb-mCherry 的表达与成年组织中的内源性 Cygb 相关。在 Cygb-TG 小鼠中单次给予(50mg/kg)硫代乙酰胺(TAA)后,丙氨酸转氨酶和氧化应激水平低于 WT 小鼠。在 TAA 给药 10 周后,Cygb-TG 肝脏表现出中性粒细胞积聚、细胞因子表达和纤维化减少,但静止的 HSCs 水平较高。与 WT 细胞相比,从 Cygb-TG 小鼠(HSC)分离的原代 HSCs 在培养的第 4 天,α-平滑肌肌动蛋白(αSMA)、胶原 1α1 和转化生长因子 β-3 的 mRNA 水平显著降低。HSCs 对 HO 诱导的 αSMA 表达具有抗性。因此,Cygb 的细胞特异性过表达可减弱 HSC 激活,并通过维持 HSC 静止来保护小鼠免受 TAA 诱导的肝纤维化,这可能是通过维持 HSC 静止来实现的。Cygb 可能是一种新的抗纤维化治疗靶点。